Helen Bulbeck

1.9k total citations
50 papers, 867 citations indexed

About

Helen Bulbeck is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Helen Bulbeck has authored 50 papers receiving a total of 867 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 20 papers in Pulmonary and Respiratory Medicine and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Helen Bulbeck's work include Glioma Diagnosis and Treatment (24 papers), Brain Metastases and Treatment (10 papers) and Childhood Cancer Survivors' Quality of Life (7 papers). Helen Bulbeck is often cited by papers focused on Glioma Diagnosis and Treatment (24 papers), Brain Metastases and Treatment (10 papers) and Childhood Cancer Survivors' Quality of Life (7 papers). Helen Bulbeck collaborates with scholars based in United Kingdom, Netherlands and United States. Helen Bulbeck's co-authors include Alasdair G Rooney, Michael D. Jenkinson, Robin Grant, Theresa A Lawrie, Florien Boele, Colin Watts, Luke Vale, Damiano G. Barone, Michael G. Hart and Andrew Bryant and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Lancet Oncology and Clinical Cancer Research.

In The Last Decade

Helen Bulbeck

46 papers receiving 845 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helen Bulbeck United Kingdom 13 400 239 238 148 145 50 867
Mirjam Renovanz Germany 19 376 0.9× 237 1.0× 177 0.7× 144 1.0× 100 0.7× 74 1.1k
Richard Rovin United States 17 235 0.6× 267 1.1× 140 0.6× 291 2.0× 113 0.8× 57 1.1k
Jan Coburger Germany 22 657 1.6× 392 1.6× 184 0.8× 160 1.1× 76 0.5× 60 1.1k
Lars Klæboe Norway 18 257 0.6× 290 1.2× 159 0.7× 150 1.0× 82 0.6× 30 1.3k
Sang-Hue Yen Taiwan 17 253 0.6× 187 0.8× 153 0.6× 121 0.8× 104 0.7× 42 886
Simon Hanft United States 15 204 0.5× 208 0.9× 131 0.6× 193 1.3× 55 0.4× 61 691
Noah D. Sabin United States 19 550 1.4× 108 0.5× 510 2.1× 199 1.3× 365 2.5× 52 1.4k
Derek S. Tsang Canada 17 539 1.3× 215 0.9× 438 1.8× 264 1.8× 39 0.3× 117 1.1k
Arimantas Tamašauskas Lithuania 21 288 0.7× 203 0.8× 221 0.9× 248 1.7× 42 0.3× 96 1.3k
Johan A F Koekkoek Netherlands 22 885 2.2× 144 0.6× 350 1.5× 117 0.8× 263 1.8× 79 1.4k

Countries citing papers authored by Helen Bulbeck

Since Specialization
Citations

This map shows the geographic impact of Helen Bulbeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Bulbeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Bulbeck more than expected).

Fields of papers citing papers by Helen Bulbeck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Bulbeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Bulbeck. The network helps show where Helen Bulbeck may publish in the future.

Co-authorship network of co-authors of Helen Bulbeck

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Bulbeck. A scholar is included among the top collaborators of Helen Bulbeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Bulbeck. Helen Bulbeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sivell, Stephanie, Ameeta Retzer, Annmarie Nelson, et al.. (2025). Well-being and coping: Key aspects of unmet need of people living with glioma. Neuro-Oncology Practice. 12(3). 413–425.
2.
Jenkinson, Michael D., Helen Bulbeck, James Burns, et al.. (2025). Seizure prophylaxis in glioma surgery (SPRING): A multi-center, unblinded, randomized trial. Neuro-Oncology Practice.
3.
Price, James, MJ Tyler, James C. Lester, et al.. (2025). Primary results for the phase III trial of Toxicity Reduction using Proton Beam Therapy for Oropharyngeal Cancer (TORPEdO; CRUK/18/010). International Journal of Radiation Oncology*Biology*Physics. 123(4). 1195–1196.
4.
Rieu, Régis, Finbar Slevin, Helen Bulbeck, et al.. (2024). Best Practice for Patient-centred Radiotherapy in Clinical Trials and Beyond—A National Multidisciplinary Consensus. Clinical Oncology. 39. 103732–103732. 1 indexed citations
5.
Whitfield, Gillian, Helen Bulbeck, Laura Clifton‐Hadley, et al.. (2024). A Randomised Phase II Trial of Hippocampal Sparing Versus Conventional Whole Brain Radiotherapy After Surgical Resection or Radiosurgery in Favourable Prognosis Patients With 1–10 Brain Metastases. Clinical Oncology. 36(11). 681–689. 1 indexed citations
6.
Jenkinson, Michael D., Helen Bulbeck, Alasdair G Rooney, et al.. (2024). P18.39.A SEIZURE PROPHYLAXIS IN GLIOMA SURGERY (SPRING): A MULTI-CENTRE, UNBLINDED, RANDOMISED TRIAL. Neuro-Oncology. 26(Supplement_5). v106–v106. 2 indexed citations
7.
Derby, Sarah, Mark R. Jackson, Karin Williams, et al.. (2024). Concurrent Olaparib and Radiation Therapy in Older Patients With Newly Diagnosed Glioblastoma: The Phase 1 Dose-Escalation PARADIGM Trial. International Journal of Radiation Oncology*Biology*Physics. 118(5). 1371–1378. 13 indexed citations
8.
Retzer, Ameeta, Stephanie Sivell, Annmarie Nelson, et al.. (2023). Development of a core outcome set for use in adult primary glioma phase III interventional trials: A mixed methods study. Neuro-Oncology Advances. 5(1). vdad096–vdad096. 4 indexed citations
9.
Retzer, Ameeta, Stephanie Sivell, Annmarie Nelson, et al.. (2022). Development of a core outcome set and identification of patient-reportable outcomes for primary brain tumour trials: protocol for the COBra study. BMJ Open. 12(9). e057712–e057712. 7 indexed citations
10.
Watts, Colin, Joshua Savage, Amit Patel, et al.. (2022). Protocol for the Tessa Jowell BRAIN MATRIX Platform Study. BMJ Open. 12(9). e067123–e067123. 4 indexed citations
11.
Plaha, Puneet, Sophie Camp, Jonathan Cook, et al.. (2022). FUTURE-GB: functional and ultrasound-guided resection of glioblastoma – a two-stage randomised control trial. BMJ Open. 12(11). e064823–e064823. 12 indexed citations
12.
Retzer, Ameeta, Stephanie Sivell, Kathy Seddon, et al.. (2022). The Experiences of People With Glioma and Their Caregivers: Living With Uncertainty and Long Term Consequences (COBra Study). Neuro-Oncology. 24(Supplement_4). iv2–iv2. 1 indexed citations
13.
Albarqouni, Loai, et al.. (2022). Evaluation of evidence supporting NICE recommendations to change people's lifestyle in clinical practice: cross sectional survey. SHILAP Revista de lepidopterología. 1(1). e000130–e000130. 6 indexed citations
14.
Zwinkels, Hanneke, Linda Dirven, Helen Bulbeck, et al.. (2021). Identification of characteristics that determine behavioral and personality changes in adult glioma patients. Neuro-Oncology Practice. 8(5). 550–558. 2 indexed citations
15.
Grant, Robin, Therese Dowswell, E. Tomlinson, et al.. (2020). Interventions to reduce the time to diagnosis of brain tumours. Cochrane Database of Systematic Reviews. 2020(9). CD013564–CD013564. 6 indexed citations
16.
Hanna, Catherine, Theresa A Lawrie, Ewelina Rogozińska, et al.. (2020). Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis. Cochrane Database of Systematic Reviews. 2020(3). CD013261–CD013261. 49 indexed citations
17.
Sage, William M., Helen Bulbeck, John D. Pickard, et al.. (2019). <p>Defining unmet clinical need across the pathway of brain tumor care: a patient and carer perspective</p>. Cancer Management and Research. Volume 11. 2189–2202. 6 indexed citations
18.
Ahmad, Saif, Marka R. Crittenden, Phuoc T. Tran, et al.. (2018). Clinical Development of Novel Drug–Radiotherapy Combinations. Clinical Cancer Research. 25(5). 1455–1461. 46 indexed citations
19.
Gillespie, David, et al.. (2016). Neurocognitive Deficits and Neurocognitive Rehabilitation in Adult Brain Tumors. Current Treatment Options in Neurology. 18(5). 22–22. 44 indexed citations
20.
Jenkinson, Michael D., Mohsen Javadpour, Brian Haylock, et al.. (2015). The ROAM/EORTC-1308 trial: Radiation versus Observation following surgical resection of Atypical Meningioma: study protocol for a randomised controlled trial. Trials. 16(1). 519–519. 151 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mirjam Renovanz Breakdown of academic impact, for papers by Richard Rovin Breakdown of academic impact, for papers by Jan Coburger Breakdown of academic impact, for papers by Lars Klæboe Breakdown of academic impact, for papers by Sang-Hue Yen Breakdown of academic impact, for papers by Simon Hanft Breakdown of academic impact, for papers by Noah D. Sabin Breakdown of academic impact, for papers by Derek S. Tsang Breakdown of academic impact, for papers by Arimantas Tamašauskas Breakdown of academic impact, for papers by Johan A F Koekkoek
Rankless by CCL
2026